MM+M has launched the survey for the 2022 version of its Agency 100 ranking of North America’s medical marketing agencies. The survey, through which MM+M compiles the data that informs its Top 100 selections, can be accessed here.

This year’s Agency 100 coverage will be published across MM+M’s digital channels on June 7 and in the June print edition of the magazine. As in years past, it will include profiles of the Top 100 medical marketing agencies and consultancies, plus the Ones to Watch feature on up-and-coming firms and an updated version of MM+M’s Agency Family Tree.

Companies that wish to be considered for the Agency 100 are asked to share information about their 2021 results, financial and otherwise. Only companies whose North American revenue places them among the Top 100 firms will be considered for an individual profile.

“Given the abundance of M&A activity and investment from private equity firms, it’s clear that the medical marketing agency space is as vibrant as it’s ever been,” said MM+M editor-in-chief Larry Dobrow. “The Agency 100 remains the definitive guide to the agency world, highlighting top performers and offering the broadest state-of-the-union assessment of its competitive dynamics.”

To be considered for the MM+M Agency 100, companies must complete the survey by Monday, March 7 at 9 p.m. ET. MM+M can accept completed surveys after that date (and up until Monday, March 14), but the Top 100 will likely be chosen soon after the March 7 deadline.

Agencies selected for a profile will be contacted by an MM+M reporter by the end of March. For questions or further information about Agency 100 editorial, contact [email protected]. For commercial opportunities, contact [email protected].